NCT01291303

Brief Summary

The analysis of flow and pressure curves generated by ventilators can be useful in the individuation of patient-ventilator asynchrony, notably in COPD patients. To date, however, a real clinical benefit of this approach to optimize ventilator setting has not been proven. The aim of the present study was to compare: optimized ventilation, driven by the analysis of flow and pressure curves, and standard setting (same initial setting, same time at the bedside, same physician, while the ventilator screen was obscured with numerical data always available). The primary aim was the normalization of pH at two hours, whilst secondary aims were change in PaCO2, respiratory rate, patient's tolerance to ventilation (all parameter evaluated at baseline, 30, 120, 360 minutes and 24 hours after the beginning of ventilation). 70 patients (26 females, aged 78±9 years, PaCO2 74±15 mmHg, pH 7.28±0.05, mean±SD) have been enrolled, with no basal difference between the two groups.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2009

Geographic Reach
2 countries

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 7, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 8, 2011

Completed
Last Updated

February 8, 2011

Status Verified

October 1, 2010

Enrollment Period

11 months

First QC Date

February 7, 2011

Last Update Submit

February 7, 2011

Conditions

Keywords

Non invasive ventilationacute exacerbation of COPDoptimized ventilation

Outcome Measures

Primary Outcomes (1)

  • arterial pH

    The primary outcome was the normalization of arterial pH (=pH≥7.35) at 2 hours from the beginning of non invasive ventilation

    2 hours

Secondary Outcomes (4)

  • carbon dioxide tension in arterial blood (PaCO2)

    120, 360 minutes and 24 hours

  • respiratory rate (RR)

    120, 360 minutes and 24 hours after the beginning of ventilation

  • patient's tolerance to ventilation

    30, 120, 360 minutes and 24 hours after the beginning of ventilation

  • mortality

    30 days

Study Arms (2)

1- optimized ventilation

EXPERIMENTAL

35 COPD patients ventilated for acute exacerbations in NIV with pressure support mode.

Procedure: Optimized ventilation

2-standard setting of ventilation

EXPERIMENTAL

35 COPD patients ventilated for acute exacerbations in NIV with pressure support mode.

Procedure: Standard ventilation

Interventions

Patients, ventilated in pressure support mode, were ventilated with initial setting PEEP and pressure support of 4 and as maximum tolerated cmH2O, inspiratory and expiratory trigger of 5 L/min and 50% of peak inspiratory flow, with changes driven by the analysis of flow and pressure curves; with a FiO2 to reach a SpO2 level between 88 and 92%.

1- optimized ventilation

Patients, ventilated in pressure support mode, were ventilated with standard setting of ventilation: -same initial setting, same time at the bedside (15 minutes at the beginning of NIV, and 5 minutes at each patients' new evaluation) same physician that "optimized ventilation" mode, while the ventilator screen was obscured (numerical data were, however, always available).

2-standard setting of ventilation

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive patients aged \> 40 years affected by COPD exacerbation (defined as an acute change in a patient's baseline dyspnoea, cough and/or sputum beyond day-to-day variability sufficient to warrant a change in therapy), and respiratory acidosis (pH \< 7.35) that were treated by NIV in addition to standard medical therapy

You may not qualify if:

  • The needing of intubation
  • The lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Policlinico S.Orsola Malpighi, Università di Bologna, Pneumologia e Terapia Intensiva Respiratoria

Bologna, BO, 40138, Italy

Location

Ospedale Valduce, Emergency Departement

Como, CO, 22100, Italy

Location

Ospedale Campo di Marte, UO Pneumologia e UTSIR

Lucca, LU, 55100, Italy

Location

Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, Università degli Studi di Milano, San Paolo Hospital

Milan, Milan, 20142, Italy

Location

Ospedale S. Gerardo, Pneumologia, Università degli Studi di Milano-Bicocca

Monza, Monza, 20052, Italy

Location

Ente Ospedaliero Cantonale, Intensive Care Unit

Bellinzona, Canton Ticino, 6500, Switzerland

Location

Related Publications (1)

  • Di Marco F, Centanni S, Bellone A, Messinesi G, Pesci A, Scala R, Perren A, Nava S. Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial. Crit Care. 2011;15(6):R283. doi: 10.1186/cc10567. Epub 2011 Nov 24.

Study Officials

  • Stefano Nava, MD

    Policlinico S.Orsola Malpighi, Università di Bologna, Pneumologia e Terapia Intensiva Respiratoria Bologna, BO, Italy

    STUDY CHAIR
  • Fabiano Di Marco, MD

    Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, Università degli Studi di Milano, San Paolo Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 7, 2011

First Posted

February 8, 2011

Study Start

October 1, 2009

Primary Completion

September 1, 2010

Study Completion

October 1, 2010

Last Updated

February 8, 2011

Record last verified: 2010-10

Locations